Literature DB >> 17699361

Advanced glycation end products and nephrotoxicity of high-protein diets.

Jaime Uribarri1, Katherine R Tuttle.   

Abstract

The popularity of high-protein diets has surged recently as obesity has become more and more common in the United States and other developed nations. In view of the high prevalence of type 2 diabetes and chronic kidney disease among obese people, it is important to understand potential effects of high-protein diets on the kidney. The hypothesis that high-protein diets are nephrotoxic because of their excessive dietary advanced glycation end product (AGE) content and an increased amino acid load that enhances AGE formation in situ was explored. This review discusses the following evidence: (1) High-protein diets are deleterious to the kidney; (2) AGE are metabolic mediators of kidney damage; (3) dietary protein-derived AGE contribute to proinflammatory and pro-oxidative processes in diabetes and kidney disease; and (4) dietary protein-derived AGE produce functional and structural abnormalities that are involved in kidney damage. Future research should consider dietary AGE as a potential therapeutic target for kidney disease in obesity, diabetes, and perhaps other causes of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17699361     DOI: 10.2215/CJN.01270406

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  Loss of compliance in small arteries, but not in conduit arteries, after 6 weeks exposure to high fat diet.

Authors:  Marie Billaud; Scott R Johnstone; Brant E Isakson
Journal:  J Cardiovasc Transl Res       Date:  2012-03-31       Impact factor: 4.132

2.  Diet and Chronic Kidney Disease.

Authors:  Holly Kramer
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 3.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 4.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

5.  Glomerular cell death and inflammation with high-protein diet and diabetes.

Authors:  Rick L Meek; Renee C LeBoeuf; Sandeep A Saha; Charles E Alpers; Kelly L Hudkins; Sheryl K Cooney; Robert J Anderberg; Katherine R Tuttle
Journal:  Nephrol Dial Transplant       Date:  2013-01-12       Impact factor: 5.992

Review 6.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

Review 7.  Obesity management in adults with CKD.

Authors:  Holly Kramer; Katherine R Tuttle; David Leehey; Amy Luke; Ramon Durazo-Arvizu; David Shoham; Richard Cooper; Srinvisan Beddhu
Journal:  Am J Kidney Dis       Date:  2009-01       Impact factor: 8.860

8.  Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.

Authors:  Karly C Sourris; Anna Watson; Karin Jandeleit-Dahm
Journal:  Handb Exp Pharmacol       Date:  2021

Review 9.  Metabolic syndrome and associated chronic kidney diseases: nutritional interventions.

Authors:  P Anil Kumar; P Swathi Chitra; G Bhanuprakash Reddy
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

10.  Examination of the Effectiveness of the Healthy Empowered Active Lifestyles (HEAL) Program on Advanced Glycation End Products.

Authors:  Mathew J Gregoski; Janis Newton; Kathleen Blaylock; Sheila A O Smith; David P Turner
Journal:  Int J Environ Res Public Health       Date:  2021-05-02       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.